- Who can participate: Adults aged 18 to 65 with a specific condition may be eligible. Key factors include not having participated in another clinical trial in the last 30 days.
- Study details: Participants will attend regular clinic visits for assessments and monitoring. They will be randomly assigned to receive either the investigational treatment or a placebo.